Risperdal Consta 37.5 mg Norwe - Kinorwe - Statens legemiddelverk

risperdal consta 37.5 mg

janssen-cilag as - risperidon - pulver og væske til depotinjeksjonsvæske, suspensjon - 37.5 mg

Risperdal Consta 50 mg Norwe - Kinorwe - Statens legemiddelverk

risperdal consta 50 mg

janssen-cilag as - risperidon - pulver og væske til depotinjeksjonsvæske, suspensjon - 50 mg

Yasminelle 28 0.02 mg / 3 mg Norwe - Kinorwe - Statens legemiddelverk

yasminelle 28 0.02 mg / 3 mg

bayer ab - solna - etinyløstradiolbetadeksklatrat / drospirenon - tablett, filmdrasjert - 0.02 mg / 3 mg

Verzenios Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - bryst neoplasms - antineoplastiske midler - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Trecondi Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

trecondi

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoietisk stamcelletransplantasjon - antineoplastiske midler - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

Malfin 30 mg Norwe - Kinorwe - Statens legemiddelverk

malfin 30 mg

teva sweden ab - morfinsulfatpentahydrat - depottablett - 30 mg

Malfin 10 mg Norwe - Kinorwe - Statens legemiddelverk

malfin 10 mg

teva sweden ab - morfinsulfatpentahydrat - depottablett - 10 mg

Malfin 60 mg Norwe - Kinorwe - Statens legemiddelverk

malfin 60 mg

teva sweden ab - morfinsulfatpentahydrat - depottablett - 60 mg

Malfin 100 mg Norwe - Kinorwe - Statens legemiddelverk

malfin 100 mg

teva sweden ab - morfinsulfatpentahydrat - depottablett - 100 mg

Sandimmun 50 mg/ ml Norwe - Kinorwe - Statens legemiddelverk

sandimmun 50 mg/ ml

novartis norge (2) - ciklosporin - konsentrat til infusjonsvæske, oppløsning - 50 mg/ ml